Bioequivalency Study of 600 mg Oxcarbazepine Tablets Under Fasting Conditions
NCT00616681
·
clinicaltrials.gov ↗
NA
Phase
COMPLETED
Status
28
Enrollment
INDUSTRY
Sponsor class
Conditions
Seizures
Epilepsy
Interventions
DRUG:
Oxcarbazepine
Sponsor
Roxane Laboratories